Lexicon Pharmaceuticals Inc (LXRX)

Nov 21, 2025

Why Lexicon Pharmaceuticals Inc. stock is considered a top pick2025 Stock Rankings & Daily Market Momentum Tracking - newser.com

Nov 21, 2025

Nov 21, 2025

Can Lexicon Pharmaceuticals Inc. stock deliver consistent earnings growthWeekly Trend Recap & Reliable Intraday Trade Plans - newser.com

Nov 21, 2025

Nov 20, 2025

Will Lexicon Pharmaceuticals Inc. stock split attract more investorsBear Alert & Daily Price Action Insights - newser.com

Nov 20, 2025

Nov 20, 2025

Can Lexicon Pharmaceuticals Inc. stock resist market sell offs2025 Institutional Moves & Weekly Watchlist for Hot Stocks - newser.com

Nov 20, 2025

Nov 20, 2025

Can Lexicon Pharmaceuticals Inc. stock surprise with earnings upsideQuarterly Market Review & Accurate Buy Signal Notifications - newser.com

Nov 20, 2025

Nov 19, 2025

Transcript : Lexicon Pharmaceuticals, Inc. Presents at Jefferies London Healthcare Conference 2025, Nov-18-2025 05 - MarketScreener

Nov 19, 2025

Nov 19, 2025

Is Lexicon Pharmaceuticals Inc. stock attractive for growth ETFs2025 Earnings Surprises & Verified Technical Trade Signals - newser.com

Nov 19, 2025

Nov 19, 2025

How to manage a losing position in Lexicon Pharmaceuticals Inc.Analyst Upgrade & Verified Entry Point Signals - newser.com

Nov 19, 2025

Nov 18, 2025

Lexicon Pharmaceuticals at Jefferies London: Strategic Pipeline Progress By Investing.com - Investing.com Canada

Nov 18, 2025

Nov 16, 2025

Published on: 2025-11-16 06:10:48 - newser.com

Nov 16, 2025

Nov 15, 2025

Lexicon Pharmaceuticals: A Lottery Ticket With 3 Chances To Win (NASDAQ:LXRX) - Seeking Alpha

Nov 15, 2025

Nov 14, 2025

Lexicon Pharmaceuticals backs Type 1 diabetes research ahead of World Diabetes Day - Traders Union

Nov 14, 2025

Nov 14, 2025

What the charts say about Lexicon Pharmaceuticals Inc. todayTake Profit & Real-Time Chart Breakout Alerts - newser.com

Nov 14, 2025

Nov 13, 2025

What MACD signals say about Lexicon Pharmaceuticals Inc.July 2025 Earnings & Fast Moving Stock Watchlists - newser.com

Nov 13, 2025

Nov 12, 2025

Private Equity Firms in Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Are Its Biggest Bettors, and Their Bets Paid off as Stock Gained 17% Last Week - 富途牛牛

Nov 12, 2025

Nov 12, 2025

Broker Revenue Forecasts For Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Are Surging Higher - Yahoo Finance

Nov 12, 2025

Nov 12, 2025

Private equity firms among Lexicon Pharmaceuticals, Inc.'s (NASDAQ:LXRX) largest shareholders, saw gain in holdings value after stock jumped 17% last week - simplywall.st

Nov 12, 2025

Nov 11, 2025

Lexicon signals 2026 INPEFA profitability and eyes pilavapadin Phase III advancement while expanding global partnerships - MSN

Nov 11, 2025

Nov 11, 2025

Lexicon Pharmaceuticals Files Prospectus for Stock Sale - MSN

Nov 11, 2025

Nov 11, 2025

Lexicon Pharmaceuticals to Participate at the Jefferies 2025 London Healthcare Conference - The Manila Times

Nov 11, 2025

Nov 10, 2025

[8-K] LEXICON PHARMACEUTICALS, INC. Reports Material Event | LXRX SEC FilingForm 8-K - Stock Titan

Nov 10, 2025

Nov 10, 2025

Applying Wyckoff theory to Lexicon Pharmaceuticals Inc. stockQuarterly Performance Summary & Daily Market Momentum Tracking - newser.com

Nov 10, 2025

Nov 09, 2025

Lexicon (LXRX) Unveils Promising Sotagliflozin Data at AHA 2025 - GuruFocus

Nov 09, 2025

Nov 09, 2025

Lexicon Pharmaceuticals Stock (LXRX) Opinions on Q3 Earnings and Clinical Data - Quiver Quantitative

Nov 09, 2025

Nov 08, 2025

Lexicon Pharmaceuticals, Inc. Announces Clinical Data Demonstrating Efficacy of Sotagliflozin in Preserved Ejection Fraction Heart Failure Without Diabetes Presented At American Heart Association Annual Scientific Sessions 2025 - MarketScreener

Nov 08, 2025

Nov 08, 2025

Lexicon Pharmaceuticals Reveals Positive Clinical Data for Sotagliflozin in Heart Failure Patients Without Diabetes at AHA 2025 - Quiver Quantitative

Nov 08, 2025

Nov 08, 2025

Lexicon (NASDAQ: LXRX) reports HFpEF gains without diabetes in 6-minute walk and KCCQ - Stock Titan

Nov 08, 2025

Nov 08, 2025

Lexicon Pharmaceuticals (LXRX) Reports Q3 Loss, Beats Revenue Estimates - MSN

Nov 08, 2025

Nov 07, 2025

Analysts Offer Insights on Healthcare Companies: Schrodinger (SDGR), Lexicon Pharmaceuticals (LXRX) and Cullinan Management (CGEM) - The Globe and Mail

Nov 07, 2025

Nov 07, 2025

Lexicon Pharmaceuticals unveils new data on cardiovascular SGLT1/2 inhibitor - Traders Union

Nov 07, 2025

Nov 07, 2025

Lexicon Pharmaceuticals’ Losses Shrink As Partnerships Pay Off - Finimize

Nov 07, 2025

Nov 07, 2025

Earnings call transcript: Lexicon Pharmaceuticals beats Q3 2025 forecasts By Investing.com - Investing.com Australia

Nov 07, 2025

Nov 07, 2025

Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Q3 2025 Earnings Call Transcript - Insider Monkey

Nov 07, 2025

Nov 07, 2025

Lexicon: Q3 Earnings Snapshot - theheraldreview.com

Nov 07, 2025